New nonsteroidal anti-inflammatory drugs.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001241:Aspirin / Q000627:therapeutic use; D005279:Fenoprofen / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007052:Ibuprofen / Q000009:adverse effects / Q000627:therapeutic use*; D009280:Naphthaleneacetic Acids / Q000627:therapeutic use*; D009288:Naproxen / Q000009:adverse effects / Q000627:therapeutic use*; D010666:Phenylpropionates / Q000627:therapeutic use*; D011758:Pyrroles / Q000627:therapeutic use*; D014046:Tolmetin / Q000009:adverse effects / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D009280:Naphthaleneacetic Acids; D010666:Phenylpropionates; D011758:Pyrroles; D009288:Naproxen; D014046:Tolmetin; D001241:Aspirin; D005279:Fenoprofen; D007052:Ibuprofen